Current advances in the use of therapeutic hypothermia.

Temperature management and therapeutic hypothermia is being investigated in stroke, subarachnoid hemorrhage, myocardial infarction, and neonatal encephalopathy. Previous clinical studies have provided support for the use of hypothermia in these clinical conditions, and new studies are currently underway to establish safety and efficacy of this therapeutic intervention. Thus, this particular session brought together experts in the field of therapeutic hypothermia to discuss its use in several important patient populations. Dr. Neeraj Badjatia from the University of Maryland School of Medicine discussed antishivering strategies targeting stroke and subarachnoid hemorrhage. This lecture emphasized thermoregulatory systems and systematic approaches toward shiver control during cooling in patients with acute stroke. Various pharmacological strategies are currently used for shiver control, including drug combinations and counterwarming approaches. Dr. Christopher J. White of the Ochsner Medical Center emphasized the use of hypothermia in myocardial infarction. Myocardial infarction is an extremely important clinical problem, and the use of hypothermia to reduce ischemic injury and reperfusion-injury is currently being assessed in both preclinical and clinical studies. Previous clinical studies including a prospective randomized trial reported that postreperfusion cooling provided no significant improvement. However, recent investigations are concentrating on hypothermia treatment initiated before reperfusion, and these have been very promising. Dr. Abbot Laptook, Brown University, updated the attendees on therapeutic cooling and neonatal hypoxic ischemic encephalopathy. Results from published multicenter trials have emphasized the benefits of therapeutic hypothermia in newborn hypoxic ischemic encephalopathy patients, and issues regarding implementation of hypothermia on transport to hospitals are being evaluated along with combination approaches. Dr. Markus Foedisch from Bonn, Germany, discussed the use of brain damage markers to determine how best to utilize hypothermia after cardiac arrest. Dr. Foedisch updated the attendees regarding the cool brain register as well as the effects of cooling on available biomarkers, including neuron-specific enolase and S100B. This session had an extensive question-and-answer exchange and provided new information regarding the advances being made in the use of hypothermia in these clinical conditions.

[1]  Gavin D Perkins,et al.  Cardiac Arrest and Cardiopulmonary Resuscitation Outcome Reports: Update of the Utstein Resuscitation Registry Templates for Out-of-Hospital Cardiac Arrest: A Statement for Healthcare Professionals From a Task Force of the International Liaison Committee on Resuscitation (American Heart Association, , 2015, Resuscitation.

[2]  G. Nichol,et al.  Treatment for out-of-hospital cardiac arrest: is the glass half empty or half full? , 2014, Circulation.

[3]  C. Callaway,et al.  Apples to apples or apples to oranges? International variation in reporting of process and outcome of care for out-of-hospital cardiac arrest. , 2014, Resuscitation.

[4]  L. Køber,et al.  Targeted Temperature Management at 33°C Versus 36°C and Impact on Systemic Vascular Resistance and Myocardial Function After Out-of-Hospital Cardiac Arrest: A Sub-Study of the Target Temperature Management Trial , 2014, Circulation. Cardiovascular interventions.

[5]  G. Nichol,et al.  Prehospital therapeutic hypothermia in patients with out-of-hospital cardiac arrest--reply. , 2014, JAMA.

[6]  P. Kudenchuk,et al.  Effect of prehospital induction of mild hypothermia on survival and neurological status among adults with cardiac arrest: a randomized clinical trial. , 2014, JAMA.

[7]  J. Jenkins,et al.  Carotid artery stenting , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[8]  C. White,et al.  State‐of‐the‐art paper: Therapeutic hypothermia in out of hospital cardiac arrest survivors , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[9]  G. Weisz,et al.  Objective simulator-based evaluation of carotid artery stenting proficiency (from Assessment of Operator Performance by the Carotid Stenting Simulator Study [ASSESS]). , 2013, The American journal of cardiology.

[10]  Akbar Rahideh,et al.  In vitro cardiovascular system emulator (bioreactor) for the simulation of normal and diseased conditions with and without mechanical circulatory support. , 2013, Artificial organs.

[11]  R. Berg,et al.  Use of Therapeutic Hypothermia After In-Hospital Cardiac Arrest* , 2013, Critical care medicine.

[12]  C. White,et al.  Endovascular Stents: A Review of Their Use in Peripheral Arterial Disease , 2013, American Journal of Cardiovascular Drugs.

[13]  B. Vohr,et al.  Elevated temperature and 6‐ to 7‐year outcome of neonatal encephalopathy , 2013, Annals of neurology.

[14]  A. Laptook,et al.  Initiating therapeutic hypothermia during transport for encephalopathy: current state and future direction , 2013, Journal of Perinatology.

[15]  P. Kochanek,et al.  Developing cooling strategies targeting the heart in adults and children. , 2012, Therapeutic hypothermia and temperature management.

[16]  S. Mayer,et al.  Effects of the neurological wake-up test on clinical examination, intracranial pressure, brain metabolism and brain tissue oxygenation in severely brain-injured patients , 2012, Critical Care.

[17]  B. Poindexter,et al.  Brain injury following trial of hypothermia for neonatal hypoxic–ischaemic encephalopathy , 2012, Archives of disease in childhood. Fetal and neonatal edition.

[18]  S. Mayer,et al.  Early neurological deterioration after subarachnoid haemorrhage: risk factors and impact on outcome , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  G. Natarajan,et al.  Effect of inborn vs. outborn delivery on neurodevelopmental outcomes in infants with hypoxic–ischemic encephalopathy: secondary analyses of the NICHD whole-body cooling trial , 2012, Pediatric Research.

[20]  B. Vohr,et al.  Childhood outcomes after hypothermia for neonatal encephalopathy. , 2012, The New England journal of medicine.

[21]  S. Mayer,et al.  Hypothermia for acute brain injury—mechanisms and practical aspects , 2012, Nature Reviews Neurology.

[22]  C. White.  Acute stroke treatment: carotid "stenters" to the rescue. , 2011, Journal of the American College of Cardiology.

[23]  D. Erlinge.  A Review of Mild Hypothermia as an Adjunctive Treatment for ST-Elevation Myocardial Infarction. , 2011, Therapeutic hypothermia and temperature management.

[24]  N. Badjatia.  Fever Control in the NICU: Is There Still a Simpler and Cheaper Solution? , 2011, Neurocritical care.

[25]  S. Mayer,et al.  Relationship Between C-Reactive Protein, Systemic Oxygen Consumption, and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage , 2011, Stroke.

[26]  S. Mayer,et al.  Prevention of Shivering During Therapeutic Temperature Modulation: The Columbia Anti-Shivering Protocol , 2011, Neurocritical care.

[27]  M. Ugander,et al.  A Pilot Study of Rapid Cooling by Cold Saline and Endovascular Cooling Before Reperfusion in Patients With ST-Elevation Myocardial Infarction , 2010, Circulation. Cardiovascular interventions.

[28]  J. Cooper,et al.  Short term prognosis of patients with acute coronary syndromes: the level of cardiac troponin T elevation corresponding to the “old” WHO definition of myocardial infarction , 2005, Heart.

[29]  W. Richmond,et al.  Plasma Antioxidants: Evidence for a Protective Role against Reactive Oxygen Species following Cardiac Surgery , 1998, Annals of clinical biochemistry.

[30]  T. Sjostrand.  The electrocardiographic work and hypoxemia tests. , 1951, Scandinavian journal of clinical and laboratory investigation.